ArticleJournal of cardiovascular development and disease2025

Fibroblast Growth Factor 23 Is a Strong Predictor of Adverse Events After Left Ventricular Assist Device Implantation.

Wissam Yared et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.